Carmen Burtea

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Journal of magnetic resonance imaging : JMRI

Journal of drug targeting

Biology

University of Mons

University of Mons (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Mons Sep 01 2009

Belgium

Associate Professor :: General, Organic & Biomedical Chemistry

Education History

University of Mons Mar 01 2003 - Mar 01 2007

Belgium

PHD :: General, Organic & Biomedical Chemistry

University of Bucharest Sep 01 1992 - Dec 01 1997

Romania

PHD :: Physiology

Publications

Sébastien Boutry, Laurent Sophie, Carmen Burtea
Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging". Journal of magnetic resonance imaging : JMRI (2023)
Mihaela Balas, Daniela Predoi, Carmen Burtea, Anca Dinischiotu
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International journal of molecular sciences 24 (4) (2023)
Mihaela Balas, Daniela Predoi, Carmen Burtea, Anca Dinischiotu
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International journal of molecular sciences 24 (4) (2023)
Mihaela Balas, Daniela Predoi, Carmen Burtea, Anca Dinischiotu
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International journal of molecular sciences 24 (4) (2023)
Mihaela Balas, Daniela Predoi, Carmen Burtea, Anca Dinischiotu
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International journal of molecular sciences 24 (4) (2023)
Mihaela Balas, Daniela Predoi, Carmen Burtea, Anca Dinischiotu
New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. International journal of molecular sciences 24 (4) (2023)
Sègbédé E R Tchéoubi, Casimir D Akpovi, Frédérique Coppée, Anne-Emilie Declèves, Laurent Sophie, Clément Agbangla, Carmen Burtea
Molecular and cellular biology of PCSK9: impact on glucose homeostasis. Journal of drug targeting 30 (9) (2022)
Sébastien Boutry, Laurent Sophie, Carmen Burtea
Editorial for "New Cluster Analysis Method for Quantitative DCE-MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model". Journal of magnetic resonance imaging : JMRI 56 (6) (2022)
Deborah Crombez, Sébastien Delcambre, Denis Nonclercq, Luce Vander Elst, Sophie Laurent, Miriam Cnop, Robert N Muller, Carmen Burtea
Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models. Journal of drug targeting 28 (7-8) (2020)
Deborah Fanfone, Dimitri Stanicki, Denis Nonclercq, Marc Port, Luce Vander Elst, Laurent Sophie, Robert N Muller, Sven Saussez, Carmen Burtea
Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes. Biology 9 (3) (2020)
Ioana Mihaela Popescu Din, Mihaela Balas, Anca Oana Hermenean, Luce Vander Elst, Laurent Sophie, Carmen Burtea, Ludmila Otilia Cinteza, Anca Dinischiotu
Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement. Materials (Basel, Switzerland) 13 (12) (2020)
Séverine André, Lionel Larbanoix, Sébastien Verteneuil, Dimitri Stanicki, Denis Nonclercq, Luce Vander Elst, Laurent Sophie, Robert N Muller, Carmen Burtea
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents. Biology 9 (7) (2020)
Stéphane Demine, Alexander Balhuizen, Vinciane Debaille, Lieke Joosten, Maïté Fereau, Satya Narayana Murthy Chilla, Isabelle Millard, Raphaël Scharfmann, Dominique Egrise, Serge Goldman, Piero Marchetti, Martin Gotthardt, Laurent Sophie, Carmen Burtea, Decio L Eizirik
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa. Molecules (Basel, Switzerland) 23 (9) (2018)
Deborah Fanfone, Nadège Despretz, Dimitri Stanicki, Jenifer Rubio-Magnieto, Mathieu Fossépré, Mathieu Surin, Sandrine Rorive, Isabelle Salmon, Luce Vander Elst, Sophie Laurent, Robert N Muller, Sven Saussez, Carmen Burtea
Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1. Medical oncology (Northwood, London, England) 34 (11) (2017)

Carmen Burtea.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carmen Burtea